Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease
We evaluated short-term response endpoints for acute graft-versus-host disease treatment trials. We postulated that response endpoints should correlate with reduced symptom burden and decreased subsequent treatment failure, defined as non-relapse mortality, recurrent malignancy, or additional system...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Ferrata Storti Foundation
2014-02-01
|
| סדרה: | Haematologica |
| גישה מקוונת: | https://haematologica.org/article/view/6941 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|